Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Diabetes

  Free Subscription


29.01.2018

1 Acta Ophthalmol
1 Am J Cardiol
73 Atherosclerosis
1 Biochem Biophys Res Commun
1 Br J Ophthalmol
4 Diabet Med
4 Diabetes
19 Diabetes Care
6 Diabetes Obes Metab
4 Diabetologia
1 Eur J Endocrinol
2 Invest Ophthalmol Vis Sci
2 J Clin Endocrinol Metab
4 J Diabetes Complications
1 J Hypertens
3 JAMA
1 Lancet Diabetes Endocrinol
1 Metabolism
2 Obstet Gynecol
10 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. JANSSON RW, Hufthammer KO, Krohn J
    Diabetic retinopathy in type 1 diabetes patients in Western Norway.
    Acta Ophthalmol. 2018 Jan 25. doi: 10.1111/aos.13654.
    PubMed     Text format     Abstract available


    Am J Cardiol

  2. ECHOUFFO-TCHEUGUI JB, Kolte D, Khera S, Bhatt DL, et al
    Comparison of Survival After In-Hospital Cardiac Arrest in Patients With Versus Without Diabetes Mellitus.
    Am J Cardiol. 2017 Dec 23. pii: S0002-9149(17)31919.
    PubMed     Text format     Abstract available


    Atherosclerosis

  3. ILYAS Z, Al-Ghamdi J, Nguan-Soon T, Kiss-Toth E, et al
    Tribbles-3, a regulator of metabolic syndromes and type 2 diabetes.
    Atherosclerosis. 2017;263:e50.
    PubMed     Text format    

  4. ZIVKOVIC V, Vranic A, Simovic S, Ristic P, et al
    The acute effects of different spironolactone doses on cardiac function in streptozotocine-induced diabetic rats.
    Atherosclerosis. 2017;263:e268-e270.
    PubMed     Text format    

  5. REVNIC CR, Revnic F, Pena C, Nica AS, et al
    The role of physical training on neuroendocrine axis, physiology and metabolism in elderly with/without diabetes.
    Atherosclerosis. 2017;263:e161.
    PubMed     Text format    

  6. ZHILINA S, Miramontes Gonzalez JP, Laso Guzman FJ
    Familial hypercholesterolemia and the diabetogenic effect of statins.
    Atherosclerosis. 2017;263:e264.
    PubMed     Text format    

  7. BENEDI MVM, Calahorra SP, Sanz AMB, Baila Rueda L, et al
    A randomized, open-label study to investigate the effect of a high protein diet compared to a normoprotein diet on hydrocarbon metabolism in patients with diabetes or prediabetes and obesity.
    Atherosclerosis. 2017;263:e263.
    PubMed     Text format    

  8. NIKOLOVA A, Milanova M, Stoyanov K, Yankov G, et al
    Risk assessment for diabetes mellitus type 2 in women.
    Atherosclerosis. 2017;263:e263-e264.
    PubMed     Text format    

  9. SZTANEK F, Seres I, Lorincz H, Molnar A, et al
    Effect of alpha-lipoic acid supplementation on oxidative stress markers and antioxidative defense in patients with diabetic neuropathy.
    Atherosclerosis. 2017;263:e263.
    PubMed     Text format    

  10. CASULA M, Mozzanica F, Scotti L, Tragni E, et al
    Statin use and risk of new-onset diabetes: a meta-analysis of observational studies.
    Atherosclerosis. 2017;263:e262-e263.
    PubMed     Text format    

  11. DOULAMIS I, Tzani A, Konstantopoulos P, Antoranz A, et al
    Targeted proteomics identification of biomarkers for diabetes mellitus in patients with cardiovascular disease.
    Atherosclerosis. 2017;263:e261.
    PubMed     Text format    

  12. PARAGH G, Lorincz H, Somodi S, Varga VE, et al
    Serum afamin level is strongly associated to the components of metabolic syndrome in non-diabetic obese patients.
    Atherosclerosis. 2017;263:e261.
    PubMed     Text format    

  13. OVSYANNIKOVA A, Rymar O, Shaksthneider E, Ragino Y, et al
    The prevalence of dyslipidemia in young patients with diabetes mellitus.
    Atherosclerosis. 2017;263:e260-e261.
    PubMed     Text format    

  14. OVSYANNIKOVA A, Rymar O, Shaksthneider E, Voevoda M, et al
    Clinical case: The development of atherosclerosis in a patient 28 years old with 12 mody diabetes.
    Atherosclerosis. 2017;263:e260.
    PubMed     Text format    

  15. ENA J, Perez S, Argente CR, Lozano T, et al
    Systolic blood pressure difference between arms and peripheral arterial disease in patients with diabetes mellitus.
    Atherosclerosis. 2017;263:e270-e271.
    PubMed     Text format    

  16. ENA J, Perez S, Alvarez CE, Valls V, et al
    Triglyceride to high density lipoprotein cholesterol ratio, total cholesterol to high density lipoprotein cholesterol ratio and low ankle brachial index in patients with diabetes.
    Atherosclerosis. 2017;263:e270.
    PubMed     Text format    

  17. CAVALCANTE MARANHAO R, Franca Marques A, Guido MC, Rufo Tavares E, et al
    Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats.
    Atherosclerosis. 2017;263:e48.
    PubMed     Text format    

  18. STOJIC I, Tepic S, Petkovic A, Srejovic I, et al
    Time dependent effects of hbot on redox status in diabetic patients.
    Atherosclerosis. 2017;263:e276.
    PubMed     Text format    

  19. MANEA V, Pop C, Pop L
    Correlations of dipper profiles in diabetic patients with hypertension: the importance of ambulatory blood pressure monitoring/24 hours.
    Atherosclerosis. 2017;263:e276.
    PubMed     Text format    

  20. KYRIAZIS I, Sgouros K, Stefani D, Vallianou K, et al
    The effect of the presence and the level of dyslipidemia control on diabetic patients with first acute ischemic stroke.
    Atherosclerosis. 2017;263:e275-e276.
    PubMed     Text format    

  21. PITHA J, Pithova P, Roztocil K, Urbaniec K, et al
    Oliva-roztocil index, specific parameter of vascular damage in women suffering from diabetes mellitus.
    Atherosclerosis. 2017;263:e275.
    PubMed     Text format    

  22. KUMAR N, Khanna RK
    Anti-diabetic effect of trigonella foenum greacum seed acetone fraction in a type 2 diabetes model of rats.
    Atherosclerosis. 2017;263:e273.
    PubMed     Text format    

  23. BAUDIN B, Nekaies Y, Baudin B, Kelbousi S, et al
    Association of apolipoproteins plasma levels with PCSK9 in type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e273-e274.
    PubMed     Text format    

  24. RAJPUT S, Sinha S
    Modulation of the coexistence of diabetes and hypothyroidism on body weight gain, leptin and various metabolic aspects in wistar rats.
    Atherosclerosis. 2017;263:e272.
    PubMed     Text format    

  25. DIOSZEGI A, Vass M, Nemeth N, Sogor V, et al
    Rheopheresis treatment of diabetic foot syndrome.
    Atherosclerosis. 2017;263:e272.
    PubMed     Text format    

  26. NANASY-VASS M, Dioszegi A, Flasko A, Mechler F, et al
    Study of microcirculatory impairment in type 2 diabetic patients with symptoms of peripherial neuropathy.
    Atherosclerosis. 2017;263:e272-e273.
    PubMed     Text format    

  27. SHALAEVA E, Janabaev B, Bobabekov A, Kasimov U, et al
    Coronary computed tomographic angiography and coronary artery calcium score in patients with type 2 diabetes undergoing trans-femoral amputation in 2013 in different clinical groups.
    Atherosclerosis. 2017;263:e271-e272.
    PubMed     Text format    

  28. BARKAS F, Elisaf M, Liberopoulos E, Liamis G, et al
    Metabolic markers to predict incident diabetes in statin-treated individuals.
    Atherosclerosis. 2017;263:e259.
    PubMed     Text format    

  29. SHAKHTSHNEIDER E, Ovsyannikova A, Ivanoshchuk D, Rymar O, et al
    The spectrum of mutations in the CEL gene in early onset diabetes patients.
    Atherosclerosis. 2017;263:e259-e260.
    PubMed     Text format    

  30. ASKRI I, Kelbousi S, Sakly M, Attia N, et al
    Atorvastatin effect on phospholipid profile and distribution between lipoprotein fractions in type 2 diabetic patients with and without CAD.
    Atherosclerosis. 2017;263:e246.
    PubMed     Text format    

  31. YASUDA H, Fujiwara A, Komiya S, Haze T, et al
    Effects of rosuvastatin add-on treatment on hyperlipidemia in type 2 diabetic patients with chronic kidney disease receiving ethyl icosapentate.
    Atherosclerosis. 2017;263:e241-e242.
    PubMed     Text format    

  32. BATURINA O, Mironova O
    Clinical case of hyperlipidemia type IV in a man with diabetes, myocardial infarction and stroke.
    Atherosclerosis. 2017;263:e227-e228.
    PubMed     Text format    

  33. MAGLAPHERIDZE Z, Tabukashvili R, Kapetivadze V, Tchaava K, et al
    Treatment of dyslipidemia in diabetic type 2 patients with hypertension.
    Atherosclerosis. 2017;263:e217.
    PubMed     Text format    

  34. MARANHAO RC, Tavoni TM, Laverdy Neto OG, Sprandel MDCO, et al
    Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e217.
    PubMed     Text format    

  35. ARAGONA CO, Cairo V, Scuruchi M, Giunta L, et al
    Evaluation of Lp(a) and insulin during pregnancy in not diabetic women. Preliminary data.
    Atherosclerosis. 2017;263:e208.
    PubMed     Text format    

  36. WALUS-MIARKA M, Trojak A, Kapusta M, Idzior-Walus B, et al
    Pentraxin 3 concentration is positively associated with apo C3 and abdominal obesity in men with type 2 diabetes.
    Atherosclerosis. 2017;263:e207.
    PubMed     Text format    

  37. VASILKOVA V, Mokhort T, Naumenko E, Zmailik M, et al
    Association between systolic dysfunction and inflammation in diabetic patients with chronic kidney disease.
    Atherosclerosis. 2017;263:e191.
    PubMed     Text format    

  38. LAKHOUA Y, Ben Nacef I, Bouzid K, M'Chrirgui N, et al
    Prevalence of diabetes and frequency of cardiovascular risk factors in paramedical and administrative staff of Charles Nicolle hospital.
    Atherosclerosis. 2017;263:e180-e181.
    PubMed     Text format    

  39. VONBANK A, Saely C, Rein P, Leiherer A, et al
    The visceral adiposity index predicts cardiovascular events both in coronary artery disease patients with and in coronary artery disease patients without diabetes.
    Atherosclerosis. 2017;263:e172-e173.
    PubMed     Text format    

  40. VIKULOVA O, Bolotskaya L, Bessmertnaya E, Artemova E, et al
    Frequency of diabetic complications and HbA1C level by active screening and diabetes registry data: Comparative study.
    Atherosclerosis. 2017;263:e171.
    PubMed     Text format    

  41. KARASEK D, Gajdova J, Kubickova V, Krystynik O, et al
    Selected adipokines in patients with type 2 diabetes: Relationship to soluble markers of endothelial dysfunction-a pilot study.
    Atherosclerosis. 2017;263:e249.
    PubMed     Text format    

  42. FULOP P, Seres I, Lorincz H, Somodi S, et al
    Lipocalin 2 may be a potential biomarker of atherosclerotic complications in obese non-diabetic individuals.
    Atherosclerosis. 2017;263:e250.
    PubMed     Text format    

  43. MITSUTAKE R
    Effect of canagliflozin on visceral fat area and heart rate in patients with type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e252.
    PubMed     Text format    

  44. GARCIA-DONAIRE JA, Franch-Nadal J, Rodriguez-Fortunez P, Labrador-Barba E, et al
    The importance of the training as an integral part of caring for the diabetic patient. FORMA2 study: Differences between urban and rural work area.
    Atherosclerosis. 2017;263:e258.
    PubMed     Text format    

  45. SHALIMOVA A, Bilovol O, Bobronnikova L
    Severity of cardiovascular remodeling in comorbidity of essential hypertension and type 2 diabetes depending on genetic polymorphism of AGTR1 and IRS-1.
    Atherosclerosis. 2017;263:e258.
    PubMed     Text format    

  46. HAN Y, Jang YN, Lee YJ, Kim HM, et al
    Fimasartan nomalizes carbohydrate metabolism through AMPK pathway in diabetic condition.
    Atherosclerosis. 2017;263:e258-e259.
    PubMed     Text format    

  47. VONBANK A, Zanolin D, Leiherer A, Rein P, et al
    The power of thyroid stimulating hormone to predict cardiovascular mortality in non-obese patients is significantly modulated by type 2 diabetes.
    Atherosclerosis. 2017;263:e256.
    PubMed     Text format    

  48. SAELY C, Vonbank A, Zanolin D, Leiherer A, et al
    Single and joint effects of obesity and of the metabolic syndrome on the development of diabetes in patients with coronary atherosclerosis.
    Atherosclerosis. 2017;263:e256.
    PubMed     Text format    

  49. SAELY C, Rein P, Leiherer A, Vonbank A, et al
    Remnant cholesterol predicts the development of type 2 diabetes mellitus in patients with established coronary artery disease.
    Atherosclerosis. 2017;263:e256.
    PubMed     Text format    

  50. SAELY C, Zanolin D, Rein P, Leiherer A, et al
    Concordance of glucose-based and of HbA1c-based diagnoses of diabetes in patients with peripheral arterial disease-a comparison between men and women.
    Atherosclerosis. 2017;263:e255.
    PubMed     Text format    

  51. SAELY C, Zanolin D, Vonbank A, Leiherer A, et al
    Non-alcoholic fatty liver disease strongly predicts incident diabetes in patients with coronary artery disease.
    Atherosclerosis. 2017;263:e255-e256.
    PubMed     Text format    

  52. DEMIKHOVA N, Chernatska O, Smiianova O, Vynnychenko L, et al
    The correlation between polimorphism of CYP7a1 gene and glycated hemoglobin in hypertensive patients with type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e254.
    PubMed     Text format    

  53. KIM BJ, Han JM, Do JH, Kim BS, et al
    Sex-specific relationship between cotinine-verified second-hand smoke exposure and diabetes in 85,697 never-smokers.
    Atherosclerosis. 2017;263:e254.
    PubMed     Text format    

  54. EISENGA M, Zelle D, Sloan J, Gaillard C, et al
    High serum PCSK9 is associated with increased risk of new-onset diabetes after transplantation in renal transplant recipients.
    Atherosclerosis. 2017;263:e254-e255.
    PubMed     Text format    

  55. KONSTANTOPOULOS P, Tzani A, Doulamis IP, Korou ML, et al
    Anti-inflammatory, hypolipidemic and hepatoprotective properies of CMG in an experimental model of diabetes.
    Atherosclerosis. 2017;263:e166-e167.
    PubMed     Text format    

  56. IHM SH, Lee KY, Kim JJ, Hwang BH, et al
    CT Angiography-imaged coronary artery stenosis provides better risk prediction than traditional risk factors in asymptomatic diabetic individuals: A long-term study of clinical outcomes.
    Atherosclerosis. 2017;263:e53.
    PubMed     Text format    

  57. RAJKOVIC J, Peric M, Stanisic J, Rakocevic J, et al
    Involvement of ATP-sensitive potassium channels in effect of pinacidil on saphenous vein obtained from the patients with and without type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e131.
    PubMed     Text format    

  58. NIKOLOV A, Tsinlikov I, Tsinlikova I, Nicoloff G, et al
    Levels of anti-elastin IgA antibodies are associated with high risk of atherosclerosis in diabetics with essential hypertension.
    Atherosclerosis. 2017;263:e124-e125.
    PubMed     Text format    

  59. MELNIKOV I, Gabbasov Z, Kozlov S, Byazrova S, et al
    Assessment of novel biomarkers for restenosis occurrence after drug-eluting stent implantation in patients with stable coronary artery disease and type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e121-e122.
    PubMed     Text format    

  60. VIRTA J, Silvola J, Hellberg S, Stahle M, et al
    Effects of linagliptin intervention on atherosclerotic plaque inflammation and 18F-FDG uptake in a mouse model of type 2 diabetes.
    Atherosclerosis. 2017;263:e119-e120.
    PubMed     Text format    

  61. PETELINA T, Musikhina N, Gapon L, Emeneva I, et al
    Features of atherogenic lipid profile and inflammatory markers in patients with stable angina and type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e118.
    PubMed     Text format    

  62. KULIKOWSKI E, Calosing C, Tsujikawa L, Wasiak S, et al
    Apabetalone (RVX-208) may lower CVD events in diabetes mellitus by affecting complement pathway and microbiome activity.
    Atherosclerosis. 2017;263:e113.
    PubMed     Text format    

  63. POVLSEN GK, Langhi C, Skytte Olsen G
    Regulation of hepatic LDL-receptor and PCSK9 expression by insulin in diabetic mice and in vitro in hepatocyte models.
    Atherosclerosis. 2017;263:e102.
    PubMed     Text format    

  64. SZENTPETERI A, Lorincz H, Somodi S, Varga VE, et al
    Human obestatin level and its correlations with metabolic syndrome components in non-diabetic obese patients.
    Atherosclerosis. 2017;263:e250.
    PubMed     Text format    

  65. STOJANOVIC M, Radenkovic M
    Clarification of serotonin-induced effects in peripheral artery disease via the rat femoral artery response in models of diabetes and vascular occlusion.
    Atherosclerosis. 2017;263:e133-e134.
    PubMed     Text format    

  66. NOVAKOVIC R, Cirovic S, Markovic-Lipkovski J, Rajkovic J, et al
    Effect of polyphenol resveratrol on the isolated renal artery of normal and diabetic rats.
    Atherosclerosis. 2017;263:e157.
    PubMed     Text format    

  67. PITHOVA P, Pitha J, Stechova K, Kvapil M, et al
    Preclinical atherosclerosis is associated with insulin resistance in type 1 diabetes women.
    Atherosclerosis. 2017;263:e54.
    PubMed     Text format    

  68. DUARTE JS, Bello C, Ferreira R, Limbert C, et al
    Atherogenic dislipidemia in patients with type 2 diabetes linked to microvascular complications and heart disease.
    Atherosclerosis. 2017;263:e265.
    PubMed     Text format    

  69. WALUS-MIARKA M, Idzior-Walus B, Trojak A, Kapusta M, et al
    Pentraxin 3 concentration in patients with type 2 diabetes mellitus and NAFLD.
    Atherosclerosis. 2017;263:e54.
    PubMed     Text format    

  70. SUN Y, Kopp S, Gali CC, Zandl M, et al
    Gestational diabetes mellitus modulates cholesterol metabolism in human fetoplacental endothelial cells.
    Atherosclerosis. 2017;263:e74-e75.
    PubMed     Text format    

  71. WITKOWSKI M, Weithauser A, Tabaraie T, Steffens D, et al
    Endothelial micrornas epigenetically control vascular inflammation and thrombogenicity in diabetes.
    Atherosclerosis. 2017;263:e76.
    PubMed     Text format    

  72. EL KHOURY P, Roussel R, Fumeron F, Velho G, et al
    Plasma PCSK9 and cardiovascular events in type 2 diabetes.
    Atherosclerosis. 2017;263:e81.
    PubMed     Text format    

  73. STECHOVA K, Sklenarova J, Kratzerova T, Filipp D, et al
    Association between immune and lipid factors in women with diabetes type 1.
    Atherosclerosis. 2017;263:e97-e98.
    PubMed     Text format    

  74. KUMAR S, Sharma V
    Hypertension, obesity, diabetes, and heart failure-free survival: The cardiovascular disease lifetime risk pooling project in New Delhi, India.
    Atherosclerosis. 2017;263:e159.
    PubMed     Text format    

  75. CAMARGO GARCIA A, Garcia-Carpintero S, Lopez-Moreno J, Jimenez-Lucena R, et al
    Postprandial endotoxemia may influence the type 2 diabetes mellitus development.
    Atherosclerosis. 2017;263:e98.
    PubMed     Text format    


    Biochem Biophys Res Commun

  76. YAO C, Guo X, Yao WX, Zhang C, et al
    Cereblon (CRBN) deletion reverses streptozotocin induced diabetic osteoporosis in mice.
    Biochem Biophys Res Commun. 2018 Jan 15. pii: S0006-291X(18)30110.
    PubMed     Text format     Abstract available


    Br J Ophthalmol

  77. SANDHU HS, Eladawi N, Elmogy M, Keynton R, et al
    Automated diabetic retinopathy detection using optical coherence tomography angiography: a pilot study.
    Br J Ophthalmol. 2018 Jan 23. pii: bjophthalmol-2017-311489.
    PubMed     Text format     Abstract available


    Diabet Med

  78. KERR D, Axelrod C, Hoppe C, Klonoff DC, et al
    Diabetes and technology in 2030: a utopian or dystopian future?
    Diabet Med. 2018 Jan 22. doi: 10.1111/dme.13586.
    PubMed     Text format     Abstract available

  79. BUCH V, Varughese G, Maruthappu M
    Artificial intelligence in diabetes care.
    Diabet Med. 2018 Jan 24. doi: 10.1111/dme.13587.
    PubMed     Text format     Abstract available

  80. FEIG DS, Murphy HR
    Continuous glucose monitoring in pregnant women with Type 1 diabetes: benefits for mothers, using pumps or pens, and their babies.
    Diabet Med. 2018 Jan 20. doi: 10.1111/dme.13585.
    PubMed     Text format     Abstract available

  81. PRAHALAD P, Tanenbaum M, Hood K, Maahs DM, et al
    Diabetes technology: improving care, improving patient-reported outcomes and preventing complications in young people with Type 1 diabetes.
    Diabet Med. 2018 Jan 22. doi: 10.1111/dme.13588.
    PubMed     Text format     Abstract available


    Diabetes

  82. ZHANG K
    "NO" to Autophagy: Fat Does the Trick for Diabetes.
    Diabetes. 2018;67:180-181.
    PubMed     Text format    

  83. STEINBERG GR
    Cellular Energy Sensing and Metabolism-Implications for Treating Diabetes: The 2017 Outstanding Scientific Achievement Award Lecture.
    Diabetes. 2018;67:169-179.
    PubMed     Text format     Abstract available


  84. In This Issue of Diabetes.
    Diabetes. 2018;67:167-168.
    PubMed     Text format    

  85. KADY NM, Liu X, Lydic TA, Syed MH, et al
    ELOVL4-Mediated Production of Very Long Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.
    Diabetes. 2018 Jan 23. pii: db17-1034. doi: 10.2337/db17-1034.
    PubMed     Text format     Abstract available


    Diabetes Care

  86. LESLIE RD, Grant SFA
    Teasing Diabetes Apart, One Locus at a Time.
    Diabetes Care. 2018;41:224-226.
    PubMed     Text format    

  87. BARR ELM, Barzi F, Hughes JT, Jerums G, et al
    High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Diabetes Care. 2018 Jan 24. pii: dc17-1919. doi: 10.2337/dc17-1919.
    PubMed     Text format     Abstract available

  88. EISENBERG COLMAN MH, Quick VM, Lipsky LM, Dempster KW, et al
    Disordered Eating Behaviors Are Not Increased by an Intervention to Improve Diet Quality but Are Associated With Poorer Glycemic Control Among Youth With Type 1 Diabetes.
    Diabetes Care. 2018 Jan 25. pii: dc17-0090. doi: 10.2337/dc17-0090.
    PubMed     Text format     Abstract available

  89. PYATAK EA, Carandang K, Vigen CLP, Blanchard J, et al
    Occupational Therapy Intervention Improves Glycemic Control and Quality of Life Among Young Adults With Diabetes: the Resilient, Empowered, Active Living With Diabetes (REAL Diabetes) Randomized Controlled Trial.
    Diabetes Care. 2018 Jan 19. pii: dc17-1634. doi: 10.2337/dc17-1634.
    PubMed     Text format     Abstract available

  90. LEGA IC, Austin PC, Fischer HD, Fung K, et al
    The Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study.
    Diabetes Care. 2018 Jan 19. pii: dc17-2012. doi: 10.2337/dc17-2012.
    PubMed     Text format     Abstract available

  91. ROBERTS TJ, Burns AT, MacIsaac RJ, MacIsaac AI, et al
    Diagnosis and Significance of Pulmonary Microvascular Disease in Diabetes.
    Diabetes Care. 2018 Jan 19. pii: dc17-1904. doi: 10.2337/dc17-1904.
    PubMed     Text format     Abstract available


  92. In This Issue of Diabetes Care.
    Diabetes Care. 2018;41:207-208.
    PubMed     Text format    

  93. MANTOVANI A, Byrne CD, Bonora E, Targher G, et al
    Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis.
    Diabetes Care. 2018;41:372-382.
    PubMed     Text format     Abstract available

  94. RUTTEN GEHM, van Vugt HA, de Weerdt I, de Koning E, et al
    Implementation of a Structured Diabetes Consultation Model to Facilitate a Person-Centered Approach: Results From a Nationwide Dutch Study.
    Diabetes Care. 2018 Jan 23. pii: dc17-1194. doi: 10.2337/dc17-1194.
    PubMed     Text format     Abstract available

  95. CASTELBLANCO E, Hernandez M, Castelblanco A, Gratacos M, et al
    Low-grade Inflammatory Marker Profile May Help to Differentiate Patients With LADA, Classic Adult-Onset Type 1 and Type 2 Diabetes.
    Diabetes Care. 2018 Jan 22. pii: dc17-1662. doi: 10.2337/dc17-1662.
    PubMed     Text format     Abstract available

  96. RANJAN A, Norgaard K, Tetzschner R, Steineck IIK, et al
    Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.
    Diabetes Care. 2018 Jan 22. pii: dc17-1458. doi: 10.2337/dc17-1458.
    PubMed     Text format     Abstract available

  97. MCINTYRE HD
    Discovery, Knowledge, and Action-Diabetes in Pregnancy Across the Translational Spectrum: The 2016 Norbert Freinkel Award Lecture.
    Diabetes Care. 2018;41:227-232.
    PubMed     Text format     Abstract available

  98. DABELEA D
    Diabetes in Youth-Looking Backwards to Inform the Future: Kelly West Award Lecture 2017.
    Diabetes Care. 2018;41:233-240.
    PubMed     Text format     Abstract available

  99. REYNOLDS L, Genuth SM
    The Role of Diabetes Care and Its Contributions to the Field of Diabetes: A Profile in Progress.
    Diabetes Care. 2018;41:241-249.
    PubMed     Text format    

  100. GIUGLIANO D, Maiorino MI, Bellastella G, Esposito K, et al
    Comment on Edelman and Polonsky. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 2017;40:1425-1432.
    Diabetes Care. 2018;41:e17.
    PubMed     Text format    

  101. EDELMAN SV, Polonsky WH
    Response to Comment on Edelman and Polonsky. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 2017;40:1425-1432.
    Diabetes Care. 2018;41:e18.
    PubMed     Text format    

  102. SIMINERIO LM, Albright A, Fradkin J, Gallivan J, et al
    The National Diabetes Education Program at 20 Years: Lessons Learned and Plans for the Future.
    Diabetes Care. 2018;41:209-218.
    PubMed     Text format     Abstract available

  103. LENT MR, Benotti PN, Wood GC
    Response to comment on Lent et al. All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes. Diabetes Care 2017;40:1379-1385.
    Diabetes Care. 2018;41:e20.
    PubMed     Text format    

  104. PONTIROLI AE, Zakaria AS
    Comment on Lent et al. All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes. Diabetes Care 2017;40:1379-1385.
    Diabetes Care. 2018;41:e19.
    PubMed     Text format    


    Diabetes Obes Metab

  105. LIU H, Wang L, Zhang S, Leng J, et al
    One-year weight losses in the Tianjin Gestational Diabetes Mellitus Prevention Program: A Randomized Clinical Trial.
    Diabetes Obes Metab. 2018 Jan 23. doi: 10.1111/dom.13225.
    PubMed     Text format     Abstract available

  106. KOFFERT J, Stahle M, Karlsson H, Iozzo P, et al
    Morbid obesity and type 2 diabetes alter intestinal fatty acid uptake and blood flow.
    Diabetes Obes Metab. 2018 Jan 20. doi: 10.1111/dom.13228.
    PubMed     Text format     Abstract available

  107. KREBS JD, Weatherall M, Corley B, Wiltshire E, et al
    Optimising the management of hypoglycaemia in people with Type 2 Diabetes. A randomised crossover comparison of a weight-based protocol compared with two fixed-dose glucose regimens.
    Diabetes Obes Metab. 2018 Jan 23. doi: 10.1111/dom.13231.
    PubMed     Text format     Abstract available

  108. TRAN S, Retnakaran R, Zinman B, Kramer CK, et al
    Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: A meta-analysis of randomized clinical trials.
    Diabetes Obes Metab. 2018;20 Suppl 1:68-76.
    PubMed     Text format     Abstract available

  109. TANG H, Li G, Zhao Y, Wang F, et al
    Comparisons of diabetic retinopathy events associated with glucose-lowering drugs in patients with type 2 diabetes mellitus: a network meta-analysis.
    Diabetes Obes Metab. 2018 Jan 25. doi: 10.1111/dom.13232.
    PubMed     Text format     Abstract available

  110. DANDONA P, Ghanim H, Chaudhuri A
    Incretins: Beyond type 2 diabetes.
    Diabetes Obes Metab. 2018;20 Suppl 1:59-67.
    PubMed     Text format     Abstract available


    Diabetologia

  111. MANCIA G, Grassi G
    Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach.
    Diabetologia. 2018 Jan 25. pii: 10.1007/s00125-017-4537.
    PubMed     Text format     Abstract available

  112. ZHENG F, Yan L, Yang Z, Zhong B, et al
    HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing.
    Diabetologia. 2018 Jan 25. pii: 10.1007/s00125-017-4541.
    PubMed     Text format     Abstract available

  113. HJORT L, Vryer R, Grunnet LG, Burgner D, et al
    Telomere length is reduced in 9- to 16-year-old girls exposed to gestational diabetes in utero.
    Diabetologia. 2018 Jan 23. pii: 10.1007/s00125-018-4549.
    PubMed     Text format     Abstract available

  114. SCHAEFER-GRAF U, Napoli A, Nolan CJ
    Diabetes in pregnancy: a new decade of challenges ahead.
    Diabetologia. 2018 Jan 22. pii: 10.1007/s00125-018-4545.
    PubMed     Text format     Abstract available


    Eur J Endocrinol

  115. VASILEIOU V, Kyratzoglou E, Paschou SA, Kyprianou M, et al
    The impact of environmental temperature on the diagnosis of gestational diabetes mellitus.
    Eur J Endocrinol. 2018 Jan 23. pii: EJE-17-0730. doi: 10.1530/EJE-17-0730.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  116. KIM MK, Aung MH, Mees L, Olson DE, et al
    Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2018;59:572-581.
    PubMed     Text format     Abstract available

  117. ABRAMOFF MD, Fort PE, Han IC, Jayasundera KT, et al
    Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease.
    Invest Ophthalmol Vis Sci. 2018;59:519-527.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  118. LIU L, Yan J, Xu H, Zhu Y, et al
    Two novel microRNA biomarkers related to beta-cell damage and their potential values for early diagnosis of type 1 diabetes.
    J Clin Endocrinol Metab. 2018 Jan 23. pii: 4822207. doi: 10.1210/jc.2017-01417.
    PubMed     Text format     Abstract available

  119. GAGLIANO-JUCA T
    Letter to the Editor: Myonectin Predicts the Development of Type 2 Diabetes.
    J Clin Endocrinol Metab. 2018 Jan 22. pii: 4819315. doi: 10.1210/jc.2017-02542.
    PubMed     Text format    


    J Diabetes Complications

  120. GUO J, Miller RG, Costacou T, Follansbee WP, et al
    Left ventricular systolic dysfunction predicts long-term major microvascular complication outcomes in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications (EDC) study of childhood onset diabetes.
    J Diabetes Complications. 2017 Dec 28. pii: S1056-8727(17)31383.
    PubMed     Text format     Abstract available

  121. YAJIMA T, Yajima K, Hayashi M, Takahashi H, et al
    Improved glycemic control with once-weekly dulaglutide in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring.
    J Diabetes Complications. 2017 Dec 21. pii: S1056-8727(17)31507.
    PubMed     Text format     Abstract available

  122. NANAYAKKARA N, Ranasinha S, Gadowski A, Heritier S, et al
    Age, age at diagnosis and diabetes duration are all associated with vascular complications in type 2 diabetes.
    J Diabetes Complications. 2017 Dec 7. pii: S1056-8727(17)30818.
    PubMed     Text format     Abstract available

  123. NICHOLS GA, Deruaz-Luyet A, Hauske SJ, Brodovicz KG, et al
    The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes.
    J Diabetes Complications. 2017 Dec 18. pii: S1056-8727(17)31523.
    PubMed     Text format     Abstract available


    J Hypertens

  124. EGUCHI K, Hoshide S, Kario K
    Target home morning SBP be below 125 mmHg in type 2 diabetes patients.
    J Hypertens. 2018 Jan 23. doi: 10.1097/HJH.0000000000001683.
    PubMed     Text format     Abstract available


    JAMA

  125. SALMINEN P, Helmio M, Ovaska J, Juuti A, et al
    Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
    JAMA. 2018;319:241-254.
    PubMed     Text format     Abstract available

  126. JAKOBSEN GS, Smastuen MC, Sandbu R, Nordstrand N, et al
    Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities.
    JAMA. 2018;319:291-301.
    PubMed     Text format     Abstract available

  127. SHUBECK S, Dimick JB, Telem DA
    Long-term Outcomes Following Bariatric Surgery.
    JAMA. 2018;319:302-303.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  128. PRICE AJ, Crampin AC, Amberbir A, Kayuni-Chihana N, et al
    Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi.
    Lancet Diabetes Endocrinol. 2018 Jan 19. pii: S2213-8587(17)30432.
    PubMed     Text format     Abstract available


    Metabolism

  129. NISHIHAMA K, Yasuma T, Yano Y, D' Alessandro-Gabazza CN, et al
    Anti-apoptotic activity of human matrix Metalloproteinase-2 attenuates diabetes mellitus.
    Metabolism. 2018 Jan 20. pii: S0026-0495(18)30022.
    PubMed     Text format     Abstract available


    Obstet Gynecol


  130. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus.
    Obstet Gynecol. 2018;131:e49-e64.
    PubMed     Text format     Abstract available


  131. ACOG Practice Bulletin No. 190 Summary: Gestational Diabetes Mellitus.
    Obstet Gynecol. 2018;131:406-408.
    PubMed     Text format     Abstract available


    PLoS One

  132. BONNET-SERRANO F, Diedisheim M, Mallone R, Larger E, et al
    Decreased alpha-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: An analysis based on the nPOD repository.
    PLoS One. 2018;13:e0191528.
    PubMed     Text format     Abstract available

  133. DEBUSSCHE X, Besancon S, Balcou-Debussche M, Ferdynus C, et al
    Structured peer-led diabetes self-management and support in a low-income country: The ST2EP randomised controlled trial in Mali.
    PLoS One. 2018;13:e0191262.
    PubMed     Text format     Abstract available

  134. CHAN GC, Divers J, Russell GB, Langefeld CD, et al
    Adipose tissue depot volume relationships with spinal trabecular bone mineral density in African Americans with diabetes.
    PLoS One. 2018;13:e0191674.
    PubMed     Text format     Abstract available

  135. SAKAMOTO R, Yamakawa T, Takahashi K, Suzuki J, et al
    Association of usual sleep quality and glycemic control in type 2 diabetes in Japanese: A cross sectional study. Sleep and Food Registry in Kanagawa (SOREKA).
    PLoS One. 2018;13:e0191771.
    PubMed     Text format     Abstract available

  136. LEE YH
    Socioeconomic differences among community-dwelling diabetic adults screened for diabetic retinopathy and nephropathy: The 2015 Korean Community Health Survey.
    PLoS One. 2018;13:e0191496.
    PubMed     Text format     Abstract available

  137. ALCALDE-RABANAL JE, Orozco-Nunez E, Espinosa-Henao OE, Arredondo-Lopez A, et al
    The complex scenario of obesity, diabetes and hypertension in the area of influence of primary healthcare facilities in Mexico.
    PLoS One. 2018;13:e0187028.
    PubMed     Text format     Abstract available

  138. GUO H, Wang X, Mao T, Li X, et al
    How psychosocial outcomes impact on the self-reported health status in type 2 diabetes patients: Findings from the Diabetes Attitudes, Wishes and Needs (DAWN) study in eastern China.
    PLoS One. 2018;13:e0190484.
    PubMed     Text format     Abstract available

  139. SCHRIJNDERS D, Hendriks SH, Kleefstra N, Vissers PAJ, et al
    Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49).
    PLoS One. 2018;13:e0190870.
    PubMed     Text format     Abstract available

  140. YALE JF, Pettus JH, Brito-Sanfiel M, Lavalle-Gonzalez F, et al
    The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3.
    PLoS One. 2018;13:e0190579.
    PubMed     Text format     Abstract available

  141. KIM JY, Yang S, Lee JI, Chang MJ, et al
    Correction: Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis.
    PLoS One. 2018;13:e0191744.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: